Nursing management of intraoperative malignant hyperthermia
Section: Hands on
How to quote
García de Luis G, Cavada Fernández M, Zorrilla Varela C, Sanz González M, Larrauri Cantero S, Gutiérrez de Rozas Astigarraga P. Actuación intraoperatoria ante la hipertermia maligna. Metas de Enferm nov 2012; 15(9): 63-68
Authors
Guadalupe García de Luis, Melissa Cavada Fernández, Carolina Zorrilla Varela, María Sanz González, Sandra Larrauri Cantero, Pablo Gutiérrez de Rozas Astigarrag
Position
Enfermera/o del Bloque Quirúrgico del Hospital de Laredo (Cantabria).
Contact address
Guadalupe García de Luis. C/ Reconquista de Sevilla, 29, 2º D. 39770 Laredo (Cantabria).
Contact email: lgluis@satse.es
Abstract
Malignant hyperthermia (MH) is a musculoskeletal disorder potentially fatal disease that can occur in response to inhalation of certain anesthetics and muscle relaxants (ICD-10).
In Spain, according to the Instituto Carlos III, the incidence of MH reactions ranges between 1:5,000 and 1:50,000-100,000 anesthesia procedures. However, the prevalence of genetic abnormalities that predispose to suffer MH can be as high as 1 in 3,000 individuals.
MH syndrome is fatal if untreated, but thanks to the great advances in the understanding of the clinical manifestations and pathophysiology, MH mortality was reduced to less than 5% in 2007.
The purpose of this paper is to update the knowledge on MH and present a response protocol so that the nurse is prepared: to recognize the risk factors and triggers of this condition, to detect signs and symptoms so that they can addressed immediately ,and to know how to prepare and how the method of administration of specific medication.
Versión en Español
Título:
